Updated Jul 16, 2026
Korczynski Sherry has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $66K.
Sherry Korczynski is the Chief Commercial Officer at Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing products for medical needs. She has been involved in the company's commercial strategies and operations, contributing to its product portfolio and pipeline.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | AQST | Aquestive Therapeutics, Inc. | F — Tax withholding / forfeiture | 2.7K | $0.00 | |
| 2026-03-11 | AQST | Aquestive Therapeutics, Inc. | S — Open-market sale | 15.7K | $4.17 | $66K |
| 2026-03-11 | AQST | Aquestive Therapeutics, Inc. | A — Grant or award | 75.0K | $0.00 | |
| 2025-08-14 | AQST | Aquestive Therapeutics, Inc. | A — Grant or award | 25.0K | $0.00 |
Sherry Korczynski is the Chief Commercial Officer at Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing products for medical needs. She has been involved in the company's commercial strategies and operations, contributing to its product portfolio and pipeline.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($66K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Korczynski Sherry profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.